NVS Stock Price, Chart, Stats & News

Novartis AG ADR
Save
NVS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.73% |
Operating margin | 31.25% |
Pretax margin | 29.12% |
Net margin | 24.90% |
Effective tax rate | 14.59% |
ROA | 12.10% |
ROE | 32.75% |
D/E | 0.80x |
Interest coverage ratio | 15.28x |
NVS valuation
P/E | 21.97x |
P/S | 5.10x |
P/B | 6.14x |
P/CF | 14.82x |
P/FCF | 18.31x |
P/OCF | 14.82x |
PEG | -9.32x |
EV multiple | 11.43x |
About
Novartis AG is a global healthcare enterprise dedicated to the discovery, development, production, and distribution of medical products across the world. The company operates through two main divisions: Innovative Medicines and Sandoz. Its Innovative Medicines segment provides prescription drugs to both patients and healthcare professionals, addressing a wide array of therapeutic areas such as ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory health, cardiovascular conditions, renal disorders, and metabolic diseases.
Similar securities
Based on sector and market capitalization
Report issue











